Gilead Sciences, Inc., 10% Owner at Allovir, Inc. (ALVR), bought 5,861,740 shares at $3.75 ($22.0M) on 2023-06-27, disclosed to the SEC on 2023-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 2,930,870 | $11.0M | 50.0% |
| 2 | $3.75 | 2,930,870 | $11.0M | 50.0% |
| Total | $3.75 avg | 5,861,740 | $22.0M | 100% |
| Filing → |
| XLO | BUY | 2024-12-19 | $3.7M | — | Filing → |
| XLO | BUY | 2024-04-03 | $369K | — | Filing → |
| KYTX | BUY | 2024-02-13 | $20.0M | — | Filing → |